T1	Participants 292 361	patients with chronic immune thrombocytopenia during a 6-month period
T2	Participants 437 581	adults with previously treated immune thrombocytopenia of more than 6 months' duration who had baseline platelet counts lower than 30,000 per Î¼L
T3	Participants 1467 1520	Between Nov 22, 2006, and July 31, 2007, 197 patients
